[HTML][HTML] Chronic kidney disease and arterial stiffness: a two-way path
F Inserra, P Forcada, A Castellaro… - Frontiers in Medicine, 2021 - frontiersin.org
The kidney-heart relationship has raised interest for the medical population since its vast
and complex interaction significantly impacts health. Chronic kidney disease (CKD) …
and complex interaction significantly impacts health. Chronic kidney disease (CKD) …
The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis
BM Grabias, K Konstantopoulos - American Journal of …, 2014 - journals.physiology.org
Healthy kidneys are continuously exposed to an array of physical forces as they filter the
blood: shear stress along the inner lumen of the tubules, distension of the tubular walls in …
blood: shear stress along the inner lumen of the tubules, distension of the tubular walls in …
Synbiotic supplementations for azotemia in patients with chronic kidney disease: a randomized controlled trial.
H Dehghani, F Heidari… - Iranian journal of …, 2016 - eprints.ssu.ac.ir
INTRODUCTION Chronic kidney disease (CKD) is a progressive and irreversible
impairment of kidney function; if it progresses to the end-stage of CKD, dialysis or kidney …
impairment of kidney function; if it progresses to the end-stage of CKD, dialysis or kidney …
Myostatin/activin-A signaling in the vessel wall and vascular calcification
P Esposito, D Verzola, D Picciotto, L Cipriani, F Viazzi… - Cells, 2021 - mdpi.com
A current hypothesis is that transforming growth factor-β signaling ligands, such as activin-A
and myostatin, play a role in vascular damage in atherosclerosis and chronic kidney disease …
and myostatin, play a role in vascular damage in atherosclerosis and chronic kidney disease …
Preventive and therapeutic effects of MG132 by activating Nrf2‐ARE signaling pathway on oxidative stress‐induced cardiovascular and renal injury
W Cui, Y Bai, P Luo, L Miao… - Oxidative medicine and …, 2013 - Wiley Online Library
So far, cardiovascular and renal diseases have brought us not only huge economic burden
but also serious society problems. Since effective therapeutic strategies are still limited, to …
but also serious society problems. Since effective therapeutic strategies are still limited, to …
Potential role of H-ferritin in mitigating valvular mineralization
Objective—Calcific aortic valve disease is a prominent finding in elderly and in patients with
chronic kidney disease. We investigated the potential role of iron metabolism in the …
chronic kidney disease. We investigated the potential role of iron metabolism in the …
Vascular calcification in diabetes: mechanisms and implications
JK Snell-Bergeon, MJ Budoff, JE Hokanson - Current diabetes reports, 2013 - Springer
Cardiovascular disease (CVD) remains the leading cause of death among adults with
diabetes, and CVD prevention remains a major challenge. Coronary artery calcium (CAC) …
diabetes, and CVD prevention remains a major challenge. Coronary artery calcium (CAC) …
Deregulated renal calcium and phosphate transport during experimental kidney failure
WP Pulskens, M Verkaik, F Sheedfar, EP van Loon… - PLoS …, 2015 - journals.plos.org
Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease
(CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear …
(CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear …
Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy
WSG Hayhurst, A Ahmed - Springerplus, 2015 - Springer
This study aimed to create a unique assessment tool to investigate the physical activity
levels of patients suffering from chronic kidney disease (CKD). Previous studies have …
levels of patients suffering from chronic kidney disease (CKD). Previous studies have …
[HTML][HTML] Cardiovascular events and mortality in chronic kidney disease (stages I-IV)
B Quiroga, Ú Verdalles, J Reque… - Nefrologia (English …, 2013 - revistanefrologia.com
Introducción: Los eventos cardiovasculares (CV) son la primera causa de mortalidad en
pacientes con enfermedad renal crónica (ERC). El objetivo de nuestro estudio fue …
pacientes con enfermedad renal crónica (ERC). El objetivo de nuestro estudio fue …